Here at Quest, we use multiple formulations of buprenorphine to help diminish the effects of physical dependency to opioids, such as withdrawal symptoms and cravings. It is a regulated way to mitigate substance use. Buprenorphine is an opioid partial agonist and has been proven to cause less respiratory depression, lower overdose potential, and a lower dependency rate than methadone, making it easier to titrate off when the patient is ready.
Patients who are interested in Medication Assisted Treatment will attend an initial assessment with one of our psychiatric providers to create an individualized treatment plan based on the patient’s needs.
At that assessment the different formulations of buprenorphine (buprenorphine films, oral pills, or subcutaneous injection) or naltrexone will be discussed and a personalized recommendation for treatment will be provided.
